RESOLUTE Japan results were
presented on Saturday at CVIT 2011 – the 20th Annual Meeting
of the Japanese Association of Cardiovascular Intervention and
Therapeutics in Osaka – by the study’s principal investigator,
Dr. Shigeru Saito, director of Cardiology and Catheterization
Laboratories at Shonan Kamakura General Hospital in Kamakura,
Japan.
They will be used to support Medtronic’s submission to
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for
regulatory approval of the Resolute DES in Japan, the world’s
second largest market for medical devices (after the United
States). |